First Graphene’s Cement Trials and Patent Wins Signal Critical Growth Phase Ahead

First Graphene Limited reported a successful A$2.4 million capital raise alongside promising progress in its PureGRAPH-CEM product trials in the UK and South Africa, while securing key patents and expanding distribution across Asia and South America.

  • Raised A$2.4 million from institutional and professional investors
  • PureGRAPH-CEM deployed in major UK road infrastructure project with Breedon Group
  • Graphene-enhanced cement trial in South Africa shows 33% reduction in permeability
  • Secured global patents for hydrogen generation process and Kainos Technology
  • Expanded distribution network with multi-year deals in China, Vietnam, India, and Brazil
An image related to FIRST GRAPHENE LIMITED
Image source middle. ©

Financial and Operational Highlights

First Graphene Limited (ASX: FGR) has delivered a robust quarterly update for the period ending 31 March 2025, marked by a successful capital raise of A$2.4 million and combined income of approximately A$735,000. This revenue was driven by graphene sales primarily in composites and plastics, alongside grant-funded research programs. The fresh capital injection is poised to fuel the company’s ambitious commercial pipeline over the next 12 months.

Cash flow management remains solid, with over A$3.3 million in cash and equivalents at quarter-end, providing a runway of more than 12 quarters based on current operating cash flows. This financial stability underpins First Graphene’s ongoing investments in product development and market expansion.

Advancing PureGRAPH-CEM in Cement and Concrete

The quarter saw significant progress in cement and concrete applications, with the arrival of over three tonnes of PureGRAPH-CEM in Manchester for a major road infrastructure project with Breedon Group. This initiative aligns with UK government goals to enhance road durability while reducing carbon emissions, positioning First Graphene at the forefront of sustainable construction materials.

Complementing this, the company’s unique dosing pump technology was delivered to the UK, promising a cost-effective and straightforward method to integrate PureGRAPH-CEM into cement mixes. The concrete incorporating graphene is scheduled for production and testing shortly, with results expected within two months post-pour. These outcomes will be critical in validating industrial-scale benefits such as increased strength and carbon footprint reduction.

Additional trials in South Africa demonstrated a 33% reduction in permeability in graphene-enhanced concrete slabs, a key indicator of improved durability and longevity. Meanwhile, a collaboration with Lianhetech Seal Sands in the UK is underway to develop a graphene-enhanced repair mortar, aiming to improve chemical resistance and application efficiency while lowering carbon impact.

Securing Intellectual Property and Expanding Energy Applications

First Graphene fortified its intellectual property portfolio by securing global patents for a novel metal oxide deposited graphene production process, enhancing electrocatalysts used in hydrogen generation. This cost-effective method leverages abundant base metals and existing equipment, potentially disrupting the hydrogen production landscape.

Additionally, patents for the Kainos Technology in Australia and Korea further cement the company’s position in producing graphite, graphene, and hydrogen from petroleum feedstock, underscoring its commitment to alternative energy solutions and critical mineral supply chains.

Global Market Expansion

Strategic growth continued with the signing of four multi-year distribution agreements across China, Vietnam, India, and Brazil. These partnerships open doors to high-growth markets in Asia and South America, particularly targeting sectors such as textiles, coatings, composites, and polymers. This expansion not only diversifies First Graphene’s revenue streams but also enhances its global footprint in advanced materials.

Overall, the quarter’s developments reflect First Graphene’s steady march towards commercialisation and market leadership in graphene-enhanced materials, supported by strong financials, innovative technology, and expanding global partnerships.

Bottom Line?

With key trials underway and patents secured, First Graphene is poised to translate innovation into commercial momentum.

Questions in the middle?

  • When will the results from the UK road infrastructure trial be released, and how might they impact commercial adoption?
  • How will the newly secured patents influence First Graphene’s competitive positioning in hydrogen generation?
  • What are the expected revenue contributions from the new distribution agreements in Asia and South America?